Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors.

Gyuri KimMyungeun YooMin Hee HongByung-Wan LeeEun Seok KangBong-Soo ChaHye Ryun KimEun Young LeeByoung Chul Cho

Published in: Cancer chemotherapy and pharmacology (2019)

Previous steroid use and lower baseline HbA1c level may be important predictors for developing diabetes in patients with advanced solid tumors treated with PI3K inhibitors, warranting close observation and careful intervention.

Keyphrases

type diabetes
cardiovascular disease
glycemic control
randomized controlled trial
papillary thyroid
squamous cell
metabolic syndrome
skeletal muscle
young adults
weight loss